These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
578 related items for PubMed ID: 29065396
21. Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia. Kandeel EZ, El Sharkawy N, Hanafi M, Samra M, Kamel A. Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):383-393. PubMed ID: 32201129 [Abstract] [Full Text] [Related]
22. Universal monitoring of minimal residual disease in acute myeloid leukemia. Coustan-Smith E, Song G, Shurtleff S, Yeoh AE, Chng WJ, Chen SP, Rubnitz JE, Pui CH, Downing JR, Campana D. JCI Insight; 2018 May 03; 3(9):. PubMed ID: 29720577 [Abstract] [Full Text] [Related]
23. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Mohammadi S, Ghaffari SH, Shaiegan M, Zarif MN, Nikbakht M, Akbari Birgani S, Alimoghadam K, Ghavamzadeh A. Life Sci; 2016 May 01; 152():190-8. PubMed ID: 27063991 [Abstract] [Full Text] [Related]
24. ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia. Mohd Amin A, Panneerselvan N, Md Noor S, Mohtaruddin N, Sathar J, Norbaya WS, Osman R, Kee LH, Mohd Yaakub WH, Cheong SK, Abdullah M. Malays J Pathol; 2023 Apr 01; 45(1):65-76. PubMed ID: 37119247 [Abstract] [Full Text] [Related]
26. [Proportion of CD34(+)CD38(-) cell population in bone marrow of patients with de novo AML as prognostic factor of complete remission at first course of induction chemotherapy]. Zhang CP, Wei H, Wang HJ, Huai L, He K, Chen YR, Lin D, Wang JX. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct 01; 19(5):1268-72. PubMed ID: 22040986 [Abstract] [Full Text] [Related]
31. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia. Moshaver B, van Rhenen A, Kelder A, van der Pol M, Terwijn M, Bachas C, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ. Stem Cells; 2008 Dec 01; 26(12):3059-67. PubMed ID: 19096043 [Abstract] [Full Text] [Related]
35. Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment. Mony U, Jawad M, Seedhouse C, Russell N, Pallis M. Leukemia; 2008 Jul 01; 22(7):1395-401. PubMed ID: 18509353 [Abstract] [Full Text] [Related]